The primary objective of this study is to evaluate the efficacy of atacicept compared to placebo in the treatment of signs and symptoms in a subject population with active RA, inadequate response to methotrexate (MTX) and no previous exposure to anti-TNFα therapy
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00595413?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
